What the FDA labels say about taking them together
Epinephrine and raxibacumab
Raxibacumab's FDA label of January 22, 2026 names epinephrine in its boxed warning section; the epinephrine labels PlainMeds reads (4) do not name raxibacumab. The raxibacumab label: “Administer raxibacumab by intravenous infusion in monitored settings where appropriate equipment, medication (including epinephrine) and personnel trained in the management of hypersensitivity, anaphylaxis, and shock …”
Check it at the source: the epinephrine FDA label on DailyMed (effective July 13, 2026, A-S Medication Solutions); the raxibacumab FDA label on DailyMed (effective January 22, 2026, Emergent BioDefense Operations Lansing).
What does the epinephrine label say about raxibacumab?
Epinephrine's label (effective July 13, 2026) and its 3 other brand-application labels do not name raxibacumab in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Epinephrine), A-S Medication Solutions, effective July 13, 2026 (SPL set 6e811e28-0199-4df7-a916-5940c632401d), via openFDA; the full label on DailyMed
What does the raxibacumab label say about epinephrine?
Raxibacumab label, boxed warningAdminister raxibacumab by intravenous infusion in monitored settings where appropriate equipment, medication (including epinephrine) and personnel trained in the management of hypersensitivity, anaphylaxis, and shock are available [see Warnings and Precautions ( 2.3 , 5.1 )].
Raxibacumab label, warnings and precautionsDue to the risk of anaphylaxis, administer raxibacumab injection in monitored settings where appropriate equipment, medication (including epinephrine) and personnel trained to manage hypersensitivity, anaphylaxis, and shock are available.
Source: FDA drug label (Raxibacumab), BLA125349 (Human Genome Sciences Inc.), as published by Emergent BioDefense Operations Lansing, effective January 22, 2026 (SPL set f6927e91-bb46-47b3-ab66-f9d8a9d7b12a), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Epinephrine | Raxibacumab | |
|---|---|---|
| Labeled for | Asthma | n/a |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | $123.51 per unit 0.15 mg auto-injct | n/a |
| Shortage now | A presentation being discontinued | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once